(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors. The...
(Health-NewsWire.Net, April 18, 2017 ) Publisher Drug Report, "Lucentis- Drug Insights, 2017" highlights the Lucentis marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher's report covers the Global Market Assessment of the Lucentis covering the...
(Health-NewsWire.Net, April 18, 2017 ) This report studies Pharmaceutical Grade Vitamin A in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Hyperoxaluria-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Hyperoxaluria. The Publisher's Report covers the product profiles in various stages of development including...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Acute Sensorineural Hearing Loss-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Acute Sensorineural Hearing Loss. The Publisher's Report covers the product profiles...
(Health-NewsWire.Net, April 18, 2017 ) The Sales of Manuka Honey increases from 1728.8T in 2012 to 4753.4T in 2016, at a CAGR of more than 28.77%. The sales revenue of Manuka Honey increases from 184.5 Million USD in 2012 to 586.5 Million USD in 2016, at a CAGR of more than 33.53%. In 2016, the global...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Contact Dermatitis-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Contact Dermatitis. The Publisher's Report covers the product profiles in various stages of development...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Congenital Heart Disease-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Congenital Heart Disease. The Publisher's Report covers the product profiles in various stages...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Adenocarcinoma Of The Gastroesophageal Junction-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Adenocarcinoma Of The Gastroesophageal Junction. The Publisher's Report...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Adenosine A3 Receptor Antagonists-Pipeline Insights, 2017", report provides in depth insights on the pipeline drugs and their development activities around the Adenosine A3 Receptor Antagonists. The Publisher's Report covers the product profiles...
(Health-NewsWire.Net, April 18, 2017 ) Publisher's, "Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Anti-CD274 (PD-L1) Antibody. The Publisher's Report covers the product profiles in various...
(Health-NewsWire.Net, April 18, 2017 ) Juvenile Macular Degeneration (Stargardt Disease)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Juvenile Macular Degeneration (Stargardt Disease). The Report covers the product...
(Health-NewsWire.Net, April 18, 2017 ) According to Publisher, the Global Electronic Medical Records market is accounted for $24.02 billion in 2015 and is expected to reach $36.5 billion by 2022 growing at a CAGR of 6.05% from 2015 to 2022. Growing incidence for number of diseases and rapidly increasing...
(Health-NewsWire.Net, April 18, 2017 ) According to Publisher, the Cord Blood Banking Services market accounted for $12.50 billion in 2015 and is expected to grow at a CAGR of 6.41% to reach $19.32 billion by 2022. The factors such as increasing stem cell therapy applications in diseased treatments,...
(Health-NewsWire.Net, April 18, 2017 ) According to Publisher, the Global Human Microbiome Market is accounted for $130.23 million in 2015 and is expected to reach $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period. Increasing incidence of lifestyle diseases, growing geriatric...
|